SYBX - PRICE - Synlogic, Inc.

Synlogic, Inc. (SYBX) seeks to capture vacant niches in the therapy of metabolic disorders by leveraging its proprietary developments in live bacteria. The business relies on the creation of modified probiotics in US laboratories supported by grants. This asset price chart, with a current reading of , reflects the price action. However, a profound strategic overhaul and the suspension of several trials are forcing the market to cautiously assess the company's prospects.

For an investor in Synlogic, Inc. (SYBX), understanding the market value of assets is critical amid a radical shift in the business model and the search for strategic buyers. This indicator reflects the current market equilibrium of supply and demand, allowing the real-time valuation of the company to be compared with historical lows and highs during the intellectual property restructuring period through the price action of the securities.